134 related articles for article (PubMed ID: 23369310)
21. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases.
Müller H; Nakchbandi V
Eur J Surg Oncol; 2004 Jun; 30(5):573-7. PubMed ID: 15135489
[TBL] [Abstract][Full Text] [Related]
23. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
Aarts F; Bleichrodt RP; de Man B; Lomme R; Boerman OC; Hendriks T
Ann Surg Oncol; 2008 Nov; 15(11):3299-307. PubMed ID: 18712445
[TBL] [Abstract][Full Text] [Related]
24. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome.
Macrì A; Maugeri I; Trimarchi G; Caminiti R; Saffioti MC; Incardona S; Sinardi A; Irato S; Altavilla G; Adamo V; Versaci A; Famulari C
In Vivo; 2009; 23(1):147-50. PubMed ID: 19368140
[TBL] [Abstract][Full Text] [Related]
26. Current status and future directions in gastric cancer with peritoneal dissemination.
Glockzin G; Piso P
Surg Oncol Clin N Am; 2012 Oct; 21(4):625-33. PubMed ID: 23021720
[TBL] [Abstract][Full Text] [Related]
27. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.
McQuellon RP; Loggie BW; Fleming RA; Russell GB; Lehman AB; Rambo TD
Eur J Surg Oncol; 2001 Feb; 27(1):65-73. PubMed ID: 11237495
[TBL] [Abstract][Full Text] [Related]
28. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.
Glehen O; Cotte E; Schreiber V; Sayag-Beaujard AC; Vignal J; Gilly FN
Br J Surg; 2004 Jun; 91(6):747-54. PubMed ID: 15164446
[TBL] [Abstract][Full Text] [Related]
29. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results].
Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB
Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
[TBL] [Abstract][Full Text] [Related]
31. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Chua TC; Morris DL; Esquivel J
Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
[TBL] [Abstract][Full Text] [Related]
32. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
33. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.
Franko J; Gusani NJ; Holtzman MP; Ahrendt SA; Jones HL; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2008 Nov; 15(11):3065-72. PubMed ID: 18712450
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
Akiyama H; Kunisaki C; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2168-73. PubMed ID: 12484029
[TBL] [Abstract][Full Text] [Related]
35. Regional but fatal: Intraperitoneal metastasis in gastric cancer.
Wei J; Wu ND; Liu BR
World J Gastroenterol; 2016 Sep; 22(33):7478-85. PubMed ID: 27672270
[TBL] [Abstract][Full Text] [Related]
36. Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
Tuttle TM; Zhang Y; Greeno E; Knutsen A
Ann Surg Oncol; 2006 Dec; 13(12):1627-32. PubMed ID: 17013686
[TBL] [Abstract][Full Text] [Related]
37. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
38. Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer.
Hultman B; Lundkvist J; Glimelius B; Nygren P; Mahteme H
Acta Oncol; 2012 Jan; 51(1):112-21. PubMed ID: 22070666
[TBL] [Abstract][Full Text] [Related]
39. Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis.
Sayag-Beaujard AC; Francois Y; Glehen O; Sadeghi-Looyeh B; Bienvenu J; Panteix G; Garbit F; Grandclément E; Vignal J; Gilly FN
Anticancer Res; 1999; 19(2B):1375-82. PubMed ID: 10365109
[TBL] [Abstract][Full Text] [Related]
40. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study.
Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
Ann Surg; 2011 Jul; 254(1):125-30. PubMed ID: 21502859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
